Yes, I think the 10k will reinforce the attributes of IMMD -- 3 excellent product lines, 2 that are new; very strong balance sheet and capital structure, no overhang, no toxic debt; strong marketing and customer service capabilities; and a significant presence in large growing markets, immune support, skin care, anti-aging, hair loss treatments.
It is this significant array of fundamental factors that will convince investors of the inherent value of IMMD and propel the s/p higher.